Agios Pharmaceuticals price to sales ratio AGIO
Market value divided by revenue over the last twelve months, since 2014.
- Today, Nov 2, 2026
- 18.2×
- 9-year median
- 42.0×
- Against its 9-year history
- 13th
- percentile: 0 is its lowest day, 100 its highest
- 9-year range
- 11.8× to 136×
- Peer median
- 1.8×
Agios Pharmaceuticals' price to sales ratio is 18.2× as of Nov 2, 2026.
That is below its 9-year median of 42.0×, lower than on 87% of days in the last 9 years.
Over that time it ranged from 11.8× in Dec 2020 to 136× in Jun 2018.
The median for 10 large drugmakers of a similar size is 1.8×.
Price to sales ratio over time
The dashed line is the 9-year median and the shaded band the middle half of its days.
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 18.2× | 18.2× | 38.2× |
| 2025 | 36.5× | 31.8× | 62.6× |
| 2024 | 57.9× | 50.5× | 107× |
| 2023 | 51.8× | 49.2× | 97.5× |
| 2022 | n/m a value too high to mean anything | ||
| 2021 | 15.2× | 15.2× | 19.9× |
| 2020 | 15.4× | 11.8× | 30.9× |
| 2019 | 25.4× | 17.6× | 43.8× |
| 2018 | 35.5× | 33.5× | 136× |
| 2017 | n/m a value too high to mean anything | ||
| 2016 | n/m a value too high to mean anything | ||
| 2015 | 55.9× | 53.7× | 70.0× |
| 2014 | 51.7× | 43.9× | 65.8× |
Against its peers
Companies in Drug Manufacturers - General nearest Agios Pharmaceuticals' size, closest first, today.
| Company | Price to sales ratio |
|---|---|
| AGIOAgios Pharmaceuticals | 18.2× |
| ANIPANI Pharmaceuticals | 1.7× |
| PAHCPhibro Animal Health | 1.0× |
| PCRXPacira BioSciences | 1.9× |
| HRMYHarmony Biosciences | 2.3× |
| ANABAnaptysbio | n/m |
| PBHPrestige Consumer Healthcare | 2.1× |
| OMEROmeros | n/m |
| AMPHAmphastar Pharmaceuticals | 1.6× |
| NRIXNurix Therapeutics | 4.0× |
| OGNOrganon | 0.6× |
| Peer median | 1.8× |
What the price to sales ratio tells you
Market value divided by revenue over the last twelve months. Useful for companies with little or no profit yet, since sales are harder to make negative than earnings.
Ignores margins entirely. A software company at 10× sales with 30% margins can be cheaper than a grocer at 1× sales with 2% margins.
More on Agios Pharmaceuticals
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.